To study mother-to-infant transmission of GB virus C/hepatitis G virus (GBV-C/HGV), blood samples of infants born to carrier mothers were collected beginning 3 months after birth and were tested for GBV-C/HGV RNA until 1 year of age. Of 2046 mothers, 2.1% were positive for GBV-C/ HGV RNA, and 25 of their infants were followed for a median of 12 months. Thirteen infants (52%) were viremic, and infection became persistent in all. Maternal GBV-C/HGV RNA levels of this group were ú10 7 copies/mL. Nucleotide sequence comparison in 5 viremic mother-infant pairs revealed a homology of 93% -98.2%, and none delivered by elective cesarean section. In comparison, of the 12 uninfected infants' mothers, 10 had lower GBV-C/HGV RNA levels (mean, 5 1 10 4 copies/ mL), and the remaining 2 high-titered mothers had elective cesarean section. Thus, high-titered maternal viremia and mode of delivery are closely associated with the mother-to-infant transmission of GBV-C/HGV to infants, and the infection usually becomes persistent. for GBV-C/HGV RNA and alanine aminotransferase (ALT) startcan also be found in patients with community-acquired hepatiing from 3 months after birth until 1 year of age (usually every tis [14] and is distributed worldwide, with a higher prevalence 2-3 months). The infected neonates and blood sampling times are in certain risk groups [9 -15].
with chronic hepatitis [9, 10] and found to be variants of the were collected from infants born to carrier mothers and were tested same virus [11] . It is transfusion-transmissible [10, 12, 13] but for GBV-C/HGV RNA and alanine aminotransferase (ALT) startcan also be found in patients with community-acquired hepatiing from 3 months after birth until 1 year of age (usually every tis [14] and is distributed worldwide, with a higher prevalence 2-3 months). The infected neonates and blood sampling times are in certain risk groups [9 -15] .
shown in figure 1 . The duration of follow-up was comparable between infected and uninfected infants.
Although perinatal transmission of GBV-C/HGV has been
The mode of delivery was classified into elective cesarean reported to occur in some instances [16 -18] , the case number section, emergent cesarean section, and normal spontaneous delivis small, and thus the prevalence, risk factors, and significance ery [20] . remain unclear. We therefore investigated the frequency of 
Materials and Methods
rum GBV-C/HGV RNA was detected by reverse transcriptionSubjects. Serum samples of 2046 consecutive pregnant women polymerase chain reaction (RT-PCR) with primers from the 5-collected from May 1995 to May 1996 and stored at 020ЊC were untranslated region of the viral genome [21] , and the positive maternal serum samples were further quantified. To screen the GBV-C/HGV genome, serum specimens from 10 pregnant women were pooled and then subjected to RT-PCR assay [12, 21] . In case type GBV-C/HGV RNA obtained with the first and second primer sets were 380 and 180 bp, respectively, while PCR products of the competitor RNA with the same primer sets were 417 and 217 bp, respectively. After ethidium bromide staining of the PCR products on electrophoresis, at the point at which the amounts of the wild type GBV-C/HGV product (380 bp) and the competitor product (417 bp) nearly equaled, the serum concentration should equal the known original concentration of the competitor RNA (2.79 1 10 07 pg/copy). Amplification and sequencing of the putative E2 region of the GBV-C/HGV genome. For viremic mother-infant pairs, the putative E2 region of the viral genome was amplified with specific primers (outer sense: 5-TCTGGAATACCTCTGGAAGG-3; antisense: 5-GCCTCCACCAGTGGTCGCGA-3; inner sense: 5-TGAGCAACGGATTGTCATGG-3; antisense: 5-GCGTGT-GGGGTTCCGCTTCT-3). This region was chosen as in previous reports [21, 23] . The amplified DNA was directly sequenced with an automatic DNA sequencer (model 373A; Applied Biosystems, Foster City, CA). The inner primer pairs were used as sequencing primers for both directions of the PCR products.
Phylogenetic analysis. A phylogenetic tree was constructed after the program of unweighted pair-group method with arithmetic HGV genome. Isolates from mother-infant pairs were compared with those from nonrelated subjects with GBV-C/HGV viremia. Statistical analysis. The categorical groups were analyzed by dilutions of competitor GBV-C/HGV RNA that differs from the Fisher's exact test and x 2 analysis. P õ .05 was considered statisti-RNA of interest by an insertion of 37 bp. The mixtures were cally significant. cotranscribed by random hexamers and coamplified by nested PCRs with two primer pairs. The outer primers consisted of primer GB-C2-s1 of genomic polarity (5-AGCCAACCCTAGACA- ( figure 2 ). These lines of evidence at the molecular level infants had normal ALT levels throughout the follow-up period. There was another mother infected with both HCV and strongly suggested that the neonates were indeed infected by their mothers.
Results
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GBV-C/HGV, but the infant was not infected by either virus. The serum GBV-C/HGV RNA levels of these 12 mothers were On the other hand, there were 12 infants not infected with GBV-C/HGV (table 1). All 12 mothers were negative for lower; 8 had levels õ5 1 10 4 copies/mL, 2 had 5 1 10 4 copies/mL, and 1 each had 5 1 10 7 and 5 1 10 8 copies/mL. HBsAg except 1, who was positive for both HBsAg and HBeAg. In addition, only her infant had elevated serum ALT Seven of the 12 had normal spontaneous delivery, while the remaining 5 received elective cesarean section. There were 2 levels twice (70 and 207 IU/L), whereas the remaining 11 mothers who had higher GBV-C/HGV RNA levels (ú1 1 10 7 copies/mL) in this group; however, both delivered by elective cesarean section and their infants did not contract GBV-C/ HGV infection. Taken together, these data show that babies born to mothers with high-titered viremia had higher risk of contracting GBV-C/HGV from their mothers (87% vs. 0, P õ .001) (table 1).
Discussion
We found among 2046 pregnant women a total of 42 (2.1%) viremic for GBV-C/HGV, a prevalence higher than that of HCV infection in the same population on Taiwan [19] . Furthermore, 52% (95% confidence interval, 32.4% -71.6%) of the viremic mothers transmitted GBV-C/HGV to their offsprings. The maternal transmission was documented by serial followup in the infants as well as by nucleotide sequence comparison of the E2 region of the viral genome. Sequence homology of this region ranged from 93% -98.2% between the 5 motherinfant pairs we analyzed, and phylogenetic analysis further showed a close genetic relatedness of the virus in each pair (figure 2).
All 13 GBV-C/HGV -infected infants were still viremic at age §9 months; they were thus likely to become chronic carri- infection, the immature immunity in the neonates might play some role. Although all 13 GBV-C/HGV -infected infants be-C/HGV and HBV infection are similar [1, 2] . In case GBV-C/HGV is proven to be pathogenic and important, it will then came persistently viremic during our follow-up, elevation of serum ALT level was noted only transiently and mildly in 3 be necessary to interrupt perinatal transmission, as has been done in HBV infection [7, 8] . Nevertheless, this is premature cases (only once in each) and remained normal thereafter. We are not sure that the ALT elevations were indeed caused by at present, since we know very little about the pathogenicity and the immunology of GBV-C/HGV infections [11 -15] . GBV-C/HGV. Even if this is true, our observations imply that the hepatic damage caused by this virus in infants may be mild
Because we used only viral RNA to define GBV-C/HGV infection, the incidence may be underestimated. This should and brief, as has been reported in adults [12 -14] . As to the elevated serum ALT levels in the only uninfected infant of also be studied by other means, such as assays for antibody to envelope protein E2 of GBV-C/HGV [25, 26] . Appearance of an HBV carrier mother, the infant had received hepatitis B immunoprophylaxis after birth [7] and the infant was negative the E2 antibody is associated with viral clearance and is mutually exclusive of serum GBV-C/HGV RNA. In view of the for HBsAg, so the cause of hepatitis remained unknown. Another infant, whose mother was positive for both anti-HCV and high rate of chronicity once the infant contracts GBV-C/HGV infection from the mother, as shown in our study, detection of GBV-C/HGV RNA, did not contract HCV or GBV-C/HGV infection; this may be due to the elective cesarean delivery in this antibody perhaps will add only limited information in this setting. this case.
The efficiency of mother-to-infant transmission of bloodIn summary, we found that high-titered maternal viremia and the mode of delivery are the determinants in maternal borne viruses generally correlates with the level of maternal viremia [2 -6] . However, a high level of maternal viremia alone transmission of GBV-C/HGV. In addition, the infection in early infancy easily became persistent, but the majority of cases were is not sufficient, provided that the maternal blood does not leak into fetal or newborn circulation [20, 24] . This is consistent not associated with hepatitis. with the findings in a large study of perinatal HCV infection [4] , in which not all high-titered carrier mothers transmit HCV to their babies. On the basis of our previous studies [3, 20] ,
